Glenmark Pharmaceuticals Inc USA data breach

Clerk's notes

Glenmark Pharmaceuticals Inc USA, a global pharmaceutical company, filed notice with Indiana authorities on March 17, 2026, regarding a data security incident. The company reported that unauthorized access to its systems occurred on or about February 27, 2026.

While the specific categories of information compromised have not been detailed, the incident indicates that personal information held by Glenmark Pharmaceuticals Inc USA may have been exposed. As a company involved in the development and manufacturing of medications, Glenmark routinely handles sensitive data.

The incident is currently under investigation to determine the full scope and impact. If you received an official data breach notification letter from Glenmark Pharmaceuticals Inc USA, it signifies that your personal information was potentially involved in this security event.

To safeguard your data, it is advisable to carefully read the notification letter for any specific guidance provided by Glenmark. Furthermore, consider monitoring your financial accounts and credit reports for any suspicious activity. Remain vigilant against unsolicited communications, such as emails or calls, that request personal details, as these could be attempts to exploit the compromised information.

Understanding your rights and potential legal options following such an incident is an important step. If your personal information was affected by the Glenmark Pharmaceuticals Inc USA data breach, you may be entitled to seek redress.

A free, no-obligation case review can help you understand the implications of this data breach for your personal situation. This review can clarify your legal position and any available remedies without promising a specific outcome or establishing an attorney-client relationship.

If a notification letter about this breach reached you, see every Indiana data breach on file or browse all cases.